Youth type 2 diabetes incidence rises tenfold
Analysis based on 6 articles · First reported Aug 23, 2026 · Last updated Aug 27, 2026
The rising incidence of youth-onset type 2 diabetes may increase long-term demand for diabetes treatments and management, potentially benefiting pharmaceutical and medical device companies. However, it also signals a growing public health burden that could strain healthcare systems and increase costs.
A study by the Colorado School of Public Health, led by Dr Tessa Crume, found that the incidence of type 2 diabetes among youth aged 10-19 in United States — Colorado increased nearly tenfold from 2002 to 2023, rising from 2.37 to 22.30 cases per 100,000. The increase accelerated in recent years, with annual growth of 4.72% from 2014 to 2023. Type 1 diabetes incidence rose only slightly. The findings, to be presented at the European Association for the Study of Diabetes annual meeting in Milan, highlight the growing burden of youth-onset type 2 diabetes and its potential for earlier complications. The study underscores the need for better diagnostic testing and prevention efforts.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard